CaptoMD is the result of 7 years of research efforts at the CHU de Québec—Université Laval with a total funding of $ 1.6M. Our vision is to improve the efficiency, quality and usability of both the clinical care process and the production of data for better care and research. CaptoMD is a cloud platform that offers a set of tools dedicated to clinicians and patients. The CaptoMD dashboard solves one of the biggest clinical needs, which is to reduce the difficulties of accessing, synthesizing and sharing information. Also, by measuring symptoms and patient-reported outcomes (PROs) and integrating this information into the dashboard, CaptoMD helps to focus the delivery of care on added value for the patient. By capturing all of the clinical data, CaptoMD resolves at the same time the difficulty of producing this information. CaptoMD has been used for prostate cancer in pilot mode for 3 years at the CHU de Québec. This project will continue our efforts to add new evidence in a clinical setting to demonstrate CaptoMD’s contribution to the practice of modern medicine. Thus, the objectives of the project are: 1. Describe the challenges of implementing CaptoMD 2. Implantation of CaptoMD in prostate cancer at the CHU de Québec 3. Evaluate the impacts of CaptoMD 4. Adapt CaptoMD to other tumor sites.